If they follow you onto PepMe, they start with 60 days free instead of 30 — and you earn a share of what they pay for their first twelve months. Tracked in the app, paid on revenue that actually cleared.
PepMe records what somebody was given and reminds them when the next one is due. It doesn't recommend a dose and it doesn't produce an outcome to advertise — so there's no before-and-after to sell, and we'd rather you didn't invent one. What the app actually does is easy to show and true: the maths, the log, the journal, the bloodwork.
You get counts — how many joined on your code, how many are paying, what that's worth. Never names, never emails, never what anybody logged. The people who followed you here trusted a health tracker with a protocol, not a mailing list, and handing you that would break the deal they thought they were making.
Between 20% and 30% of what your audience actually pays, for their first twelve months. PepMe is $8 a month, so a hundred people who stay is real money rather than a gesture. Where you land in that range depends on your audience — that part is a conversation.
It's paid on revenue that cleared, and reversed if a payment is refunded, so the number in your app is one you can rely on. Nothing is owed while somebody is still on their trial — the programme only earns when your people decide to stay.